MDxHealth (MDXH) Cost of Revenue (2021 - 2026)

MDxHealth has disclosed Cost of Revenue across 6 years of filings, most recently posting $10.8 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $10.8 million, up 22.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.2 million (up 11.97% YoY), and the FY2025 annual result was $38.2 million, up 9.55% from the prior year.
• Cost of Revenue came in at $10.8 million for Q1 2026 at MDxHealth, down from $10.9 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $10.9 million in Q4 2025 to a low of -$3.3 million in Q2 2022.
• The 5-year median for Cost of Revenue is $7.8 million (2024), against an average of $7.1 million.
• Across the five-year window, Cost of Revenue soared 307.48% in 2023 and rose 1.86% in 2025, its largest moves.
• MDxHealth's Cost of Revenue stood at $5.7 million in 2022, then advanced by 18.7% to $6.7 million in 2023, then soared by 37.09% to $9.2 million in 2024, then advanced by 17.74% to $10.9 million in 2025, then retreated by 0.79% to $10.8 million in 2026.
• The last three Cost of Revenue figures came in at $10.8 million (Q1 2026), $10.9 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.